The Pipeline Café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.
2019 Pipeline Cafe Participants:
NASA Carbon Nanotube Mesh Capsules for Long-Duration Biologics Delivery
Benjamin Young, CEO & Co-Founder, CapCell Biologics
A wearable, non-invasive nerve stimulator to treat canine osteoarthritis
Chris Czura, PhD, Co-founder and Chief Scientist, Convergent Medical Technologies, Inc.
Prevention/treatment of kidney disorders utilizing a proprietary “mesoscale” nanoparticle (MNP) drug delivery platform targeting the renal tubule epithelium
Arthur Klausner, President & CEO, Goldilocks Therapeutics, Inc.
The development of a rapid and highly-efficient platform for the isolation of human antibodies to treat infectious diseases
Raymond A. Alvarez, Phd, CEO & Co-founder, Ichor Biologics
Oral mucosal immunotherapy (OMIT), a novel method of peanut allergy immunotherapy administered via a specialized toothpaste immunotherapy delivery platform
Michael Nelson, JD, CEO, Intrommune Therapeutics
The Local Antibody Mucosal Brush Diagnostic (LAMB-Dx) Test: Overview of Five Proof-of-Concept Studies
William Reisacher, MD, Senior Scientific Advisor, Immunovent, LLC
Evaluation of innovative inhibitor of tau toxicity and aggregation in a pre-clinical model of fronto- temporal dementia
Amir Levine, Co-founder, Plico Biotech
LB protein nanofilms for industrial biotechnology application
Prof. Eugenia Pechkova, Head of Laboratories of Biophysics and Nanobiotechnology, Department of Experimental Medicine, University of Genova